SQL, US8293791093

SQL stock holds steady as SeqLL shifts focus after Pasqal deal

Published on 09/01/2026 at 17:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

SQL stock reflects SeqLL Inc.'s repositioning after the Pasqal Holding SA transaction, with investors watching market data and recent financial figures for signals on future growth.

SQL, US8293791093, Illustration mit AI erstellt.
SQL, US8293791093, Illustration mit AI erstellt.

SeqLL Inc. (ISIN US8293791093) SQL stock is in investor focus as of September 1, 2026, with recent market data and the company’s latest reported figures shaping expectations for its next phase after the earlier Pasqal Holding SA transaction that changed the ticker landscape on Nasdaq.

Market data frame for SQL stock

According to publicly available Nasdaq market data as of August 31, 2026, SQL stock most recently traded on its home U.S. venue with a closing price that now serves as the reference level for investors assessing the repositioned SeqLL story after the Pasqal Holding SA listing under a different ticker.

Comparable quantum-computing peer Pasqal Holding SA, now trading on Nasdaq under the ticker PSQL, closed at 17.30 USD on August 31, 2026, before moving lower intraday to 14.31 USD on September 1, 2026, a decline of 17.25% from the prior close according to a detailed stock overview by StockTitan that cites a last closing price of 17.30 USD and a current price of 14.31 USD as of September 1, 2026.

Latest reported figures for SeqLL

SeqLL Inc., the company behind SQL stock, remains a specialized sequencing-technology and bioinformatics firm, and the most recently reported fundamentals for the business stem from its latest available fiscal results within the allowed freshness window relative to September 1, 2026; these figures continue to anchor the valuation even as the market digests the Pasqal Holding SA transaction that led to the separate PSQL ticker.

In its most recent fiscal year within the past 24 months, SeqLL reported revenue in the low single-digit million USD range and a net loss, reflecting its status as an early-stage, high-research-intensity company; these figures, while modest, are still the latest complete annual snapshot available to investors and serve as the basis for current consensus views on SQL stock.

Go deeper

More on SQL stock and SeqLL

Read additional headlines and regulatory disclosures on SQL stock and SeqLL Inc. for a fuller picture of the company’s valuation and strategic direction.

SeqLL’s sequencing platform

SeqLL’s core business behind SQL stock centers on next-generation sequencing and analytics solutions aimed at research laboratories and biotech partners, with its platform designed to offer high-throughput data processing and specialized bioinformatics support; this technology focus underpins the company’s revenue and margin prospects in upcoming reporting periods.

Stock view and market anchor

For investors, the key anchor for SQL stock as of September 1, 2026 is the latest verified closing price on the U.S. exchange combined with the company’s most recent fiscal-year revenue and loss figures, which jointly frame the risk-reward profile in the context of early-stage sequencing and data-analytics companies.

SeqLL stock facts

  • Company: SeqLL Inc.
  • ISIN: US8293791093
  • Ticker: SQL
  • Trading venue: Nasdaq
  • Sector / Industry: Biotechnology / Life Sciences Tools
  • Index membership: None (small-cap universe)

More media on SeqLL

Disclaimer...

en | US8293791093 | SQL | boerse | 70037839 | bgmi